Co-founder and Chairman of Propel Careers
He is also presently the Managing Director, Life Sciences, at Allied Minds, Inc., a US private equity corporation.
Prior to Allied Minds, he served as a Partner at Oxford Biosciences focused on life sciences technology investing.
He joined Oxford in 2005 as an Investment Manager with 15 years of industry-related experience in both large and small companies.
He previously served as the Vice President of Business Development at St. Jude Medical (NYSE:STJ) focused on electrophysiology, interventional cardiology and peripheral vascular intervention where he was also responsible for a 20 person R&D team.
Prior to joining St. Jude Medical, Dr. Amirana was the CEO of Resolution Medical, a privately held cardiology company in Silicon Valley.
has helped raise over $60M in venture financing which resulted in three IPOs: EP Technologies, Cardima
, and MedicaLogic/Medscape.
He was a co-founder of Cardima and served there for seven years as Vice President of Marketing, Business Development and Chief Technology Officer.
He was Vice President of Marketing at MedicaLogic through its IPO which raised $101M and achieved a ~$1.1B market capitalization.
has launched cardiovascular products worldwide and holds various patents.
He received a B.S. in Mechanical Engineering from Tufts University and an M.D. from Eastern Virginia Medical School.
is a Marketing and Outreach Intern at Propel Careers
is presently doing a fellowship in economics at the Sloan School of Management at MIT
studying the economics of life science innovation.
PH.D in Biomedical Sciences at UMass Medical School
in Worcester, MA and developed her
thesis work in a collaboration project between Dr. Vivian Budnik and Dr. Marc Freeman within the Neurobiology Department there.
research area focused on how glial cells contribute to the formation and growth of synapses at the Drosophila NMJ.
time as a PH. D. student, she
pioneered the co-organization of the International workshop called "Small Brains Big Ideas" Biomedical Insights from Invertebrate Neuroscience Research, held in Santiago, Chile, in 2010.
This initiative successfully trained thirty Latin-American students in the application of genetic model systems.
Prior to her
moved to the United States to complete her
Biochemistry Masters degree in the laboratory of Paul Gardner at the Brudnick Neuropsychiatric Institute
, at UMASS
masters thesis work she
studied the transcriptional regulation of nicotinic receptors.
She has a biochemistry undergraduate degree from University of Concepcion, Chile and performed independent research with a focus on Immunology and Neurophysiology as an undergraduate student.
is energetically involved in fostering scientific interest and careers in the sciences as a current intern for Propel Careers
One of her
major undertakings is to create a connection between Propel Careers
and the Universities/Biotech companies located in the Worcester, MA Area.
She is an active member of women entrepreneurs in science and technology (WEST).
has a passion for science, innovation and self development.
As a Marketing and Outreach Intern for Propel Careers
, Jennifer is committed to building relationships with talented individuals, helping to convey scientific expertise and its significance simply and effectively, positioning clients for growth.
is constantly seeking out compelling networking events within the Boston Life Science industry, and is enthusiastic about providing a quickly accessible resource on the Propel Careers
website for various opportunities to gain insight from corporate partners and other like-minded individuals.
Jennifer is also Doctoral Candidate at Boston College
investigating the role of innate immune cells in HIV/SIV infection and AIDS associated neuropathogenesis.
recently found that specific monocyte subsets expand during both acute and chronic SIV infection and correlate with the degree of neuronal injury, strongly supporting the notion that ongoing monocyte expansion is required to drive CNS disease progression.
current research interest is examining the efficacy of therapeutics in the targeting of monocyte/macrophage activation and the trafficking of cells into the brain.
Before beginning her PhD, Jennifer gained experience in a rural Ugandan medical clinic with the Foundation for International Medical Relief in Children, where her passion for studying neurological diseases in HIV infected patients began.
Jennifer previously worked as a research associate characterizing longevity control pathways involving the Sirtuin gene family in the Paul Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School
She earned a BS in Neuroscience from Furman University, completing a thesis discussing ethanol sensitivity in β-endorphin deficient mice.